secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantheus Holdings, Inc. (LNTH)
CIK:        0001521036
Form:       8-K
Filed at:   2024-12-19T23:59:59+00:00
Accession:  0001193125-24-282047
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantheus CMO Jeff Humphrey to depart Jan 3, 2025; search underway for replacement
--------------------------------------------------------------------------------

- Jeff Humphrey, MD, resigns as Chief Medical Officer; last day January 3, 2025.
- Departure not due to disagreement with company or board on operations, clinical programs, or policies.
- CEO Brian Markison and President Paul Blanchfield assume interim leadership of R&D.
- Company has initiated a search for a new Chief Medical Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1521036/000119312524282047/0001193125-24-282047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1521036/000119312524282047/d883378d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-282047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer